Mary Thistle
Director/Board Member at ENTRADA THERAPEUTICS, INC.
Net worth: 3 270 $ as of 2024-05-30
Profile
Mary T.
Thistle is currently serving as a Director at Cocoon Biotech, Inc., and as an Independent Director at Enterome SA, Entrada Therapeutics, Inc., Vigil Neuroscience, Inc., and Q32 Bio, Inc. Previously, she held positions as an Independent Director at Alaunos Therapeutics, Inc. from 2020 to 2023, and as an Independent Director at Homology Medicines, Inc. She also served as the Senior Vice President-Business Development at Cubist Pharmaceuticals LLC from 2014 to 2015, and at PerkinElmer, Inc. from 2007 to 2008.
Additionally, she worked as the Chief Financial & Accounting Officer at Dimension Therapeutics, Inc. in 2017.
Ms. Thistle has a background in accounting and consulting, having worked at Deloitte & Touche LLP, Sierra Research & Technology, Inc., Yoshida & Sokolski PC, and as an Accountant at PerkinElmer, Inc. She holds an undergraduate degree from the University of Massachusetts, which she obtained in 1983.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-05 | 3,000 ( 0.02% ) | 3 270 $ | 2024-05-30 | |
ENTRADA THERAPEUTICS INC
-.--% | 2024-04-15 | 0 ( -.--% ) | - $ | 2024-05-30 |
-.--% | 2024-03-24 | 0 ( -.--% ) | - $ | 2024-05-30 |
VIGIL NEUROSCIENCE, INC.
-.--% | 2024-06-04 | 0 ( -.--% ) | - $ | 2024-05-30 |
Mary Thistle active positions
| Companies | Position | Start |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director/Board Member | 2021-05-03 |
| VIGIL NEUROSCIENCE, INC. | Director/Board Member | 2022-04-17 |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Director/Board Member | 2016-12-31 |
Cocoon Biotech, Inc.
 Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Former positions of Mary Thistle
| Companies | Position | End |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 2023-12-17 |
Bill & Melinda Gates Medical Research Institute
 Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Medical Research Institute is a non-profit organization based in Cambridge, MA. The institute focuses on programs aimed at reducing the burden of tuberculosis (TB), malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). Bill & Melinda Gates Medical Research Institute works through collaborating partners and organizations to develop and effectively use novel biomedical interventions to address substantial health concerns. Patrice Matchaba has been the CEO of the company since 2024. | Human Resources Officer | 2020-09-30 |
| DIMENSION THERAPEUTICS INC | Director of Finance/CFO | 2017-11-30 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 2014-12-31 |
PerkinElmer, Inc.
 PerkinElmer, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Excelitas Technologies Holding Corp., PerkinElmer, Inc. /IDS Business/ provides analytical and laboratory solutions. Prahlad Ramadhar Singh has been the CEO of the American company since 2009. | Corporate Officer/Principal | 2007-12-31 |
Training of Mary Thistle
| University of Massachusetts | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
Cocoon Biotech, Inc.
Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Sierra Research & Technology, Inc.
 Sierra Research & Technology, Inc. Information Technology ServicesTechnology Services Part of Analog Devices, Inc., Sierra Research & Technology, Inc. designs intellectual property and cores for the high speed networking and display driver markets. The company is based in Mountain View, CA. Sierra Research & Technology was acquired by Teridian Semiconductor Corp., part of Analog Devices, Inc. from May 11, 2010 on December 20, 2000. | Technology Services |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
Yoshida & Sokolski PC
 Yoshida & Sokolski PC Miscellaneous Commercial ServicesCommercial Services Yoshida & Sokolski PC is a private company based in Burlington, MA. | Commercial Services |
PerkinElmer, Inc.
PerkinElmer, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Excelitas Technologies Holding Corp., PerkinElmer, Inc. /IDS Business/ provides analytical and laboratory solutions. Prahlad Ramadhar Singh has been the CEO of the American company since 2009. | Commercial Services |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Bill & Melinda Gates Medical Research Institute
Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Medical Research Institute is a non-profit organization based in Cambridge, MA. The institute focuses on programs aimed at reducing the burden of tuberculosis (TB), malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). Bill & Melinda Gates Medical Research Institute works through collaborating partners and organizations to develop and effectively use novel biomedical interventions to address substantial health concerns. Patrice Matchaba has been the CEO of the company since 2024. | Commercial Services |
- Stock Market
- Insiders
- Mary Thistle
